Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors

P-Glycoprotein (P-gp, ABCB1) plays a significant role in determining the ADMET properties of drugs and drug candidates. Substrates of P-gp are not only subject to multidrug resistance (MDR) in tumor therapy, they are also associated with poor pharmacokinetic profiles. In contrast, inhibitors of P-gp...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 20; no. 18; pp. 5388 - 5395
Main Authors Poongavanam, Vasanthanathan, Haider, Norbert, Ecker, Gerhard F.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 15.09.2012
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:P-Glycoprotein (P-gp, ABCB1) plays a significant role in determining the ADMET properties of drugs and drug candidates. Substrates of P-gp are not only subject to multidrug resistance (MDR) in tumor therapy, they are also associated with poor pharmacokinetic profiles. In contrast, inhibitors of P-gp have been advocated as modulators of MDR. However, due to the polyspecificity of P-gp, knowledge on the molecular basis of ligand–transporter interaction is still poor, which renders the prediction of whether a compound is a P-gp substrate/non-substrate or an inhibitor/non-inhibitor quite challenging. In the present investigation, we used a set of fingerprints representing the presence/absence of various functional groups for machine learning based classification of a set of 484 substrates/non-substrates and a set of 1935 inhibitors/non-inhibitors. Best models were obtained using a combination of a wrapper subset evaluator (WSE) with random forest (RF), kappa nearest neighbor (kNN) and support vector machine (SVM), showing accuracies >70%. Best P-gp substrate models were further validated with three sets of external P-gp substrate sources, which include Drug Bank (n=134), TP Search (n=90) and a set compiled from literature (n=76). Association rule analysis explores the various structural feature requirements for P-gp substrates and inhibitors.
Bibliography:http://dx.doi.org/10.1016/j.bmc.2012.03.045
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0968-0896
1464-3391
1464-3391
DOI:10.1016/j.bmc.2012.03.045